Argus Research Maintains Buy on Cardinal Health, Raises Price Target to $309
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice TargetHot
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.
Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.